Jim Simons’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $494K | Sell |
101,427
-697
| -0.7% | -$3.9K | ﹤0.01% | 2605 |
|
|
2025
Q4 | $683K | Buy |
102,124
+15,276
| +18% | +$90.6K | ﹤0.01% | 2451 |
|
|
2025
Q3 | $381K | Buy |
86,848
+7,650
| +10% | +$36.3K | ﹤0.01% | 2904 |
|
|
2025
Q2 | $351K | Sell |
79,198
-9,172
| -10% | -$38.3K | ﹤0.01% | 2986 |
|
|
2025
Q1 | $500K | Buy |
88,370
+17,392
| +25% | +$223K | ﹤0.01% | 2744 |
|
|
2024
Q4 | $1.5M | Sell |
70,978
-1,430
| -2% | -$32.8K | ﹤0.01% | 2235 |
|
|
2024
Q3 | $1.95M | Sell |
72,408
-2,120
| -3% | -$62.5K | ﹤0.01% | 2038 |
|
|
2024
Q2 | $2.12M | Buy |
74,528
+4,280
| +6% | +$150K | ﹤0.01% | 1851 |
|
|
2024
Q1 | $2.98M | Sell |
70,248
-1,790
| -2% | -$80.5K | ﹤0.01% | 1772 |
|
|
2023
Q4 | $3.85M | Sell |
72,038
-2,430
| -3% | -$110K | 0.01% | 1509 |
|
|
2023
Q3 | $3.2M | Sell |
74,468
-753
| -1% | -$34.7K | 0.01% | 1563 |
|
|
2023
Q2 | $4.13M | Buy |
75,221
+2,220
| +3% | +$122K | 0.01% | 1535 |
|
|
2023
Q1 | $3.07M | Sell |
73,001
-430
| -0.6% | -$12.8K | ﹤0.01% | 1763 |
|
|
2022
Q4 | $2.03M | Sell |
73,431
-11,716
| -14% | -$289K | ﹤0.01% | 2055 |
|
|
2022
Q3 | $2.18M | Sell |
85,147
-14,979
| -15% | -$496K | ﹤0.01% | 1957 |
|
|
2022
Q2 | $3.6M | Buy |
100,126
+5,281
| +6% | +$238K | ﹤0.01% | 1787 |
|
|
2022
Q1 | $5.89M | Buy |
94,845
+4,250
| +5% | +$251K | 0.01% | 1470 |
|
|
2021
Q4 | $6.39M | Sell |
90,595
-17,050
| -16% | -$1.21M | 0.01% | 1350 |
|
|
2021
Q3 | $7.51M | Sell |
107,645
-15,690
| -13% | -$1.25M | 0.01% | 1206 |
|
|
2021
Q2 | $10.3M | Sell |
123,335
-19,430
| -14% | -$1.37M | 0.01% | 1153 |
|
|
2021
Q1 | $7.79M | Buy |
142,765
+21,120
| +17% | +$1.03M | 0.01% | 1355 |
|
|
2020
Q4 | $5.22M | Sell |
121,645
-3,490
| -3% | -$130K | 0.01% | 1558 |
|
|
2020
Q3 | $3.77M | Buy |
125,135
+21,922
| +21% | +$737K | ﹤0.01% | 1744 |
|
|
2020
Q2 | $3.2M | Buy |
103,213
+35,530
| +52% | +$957K | ﹤0.01% | 1901 |
|
|
2020
Q1 | $1.5M | Buy |
67,683
+14,083
| +26% | +$382K | ﹤0.01% | 2213 |
|
|
2019
Q4 | $1.64M | Buy |
53,600
+2,079
| +4% | +$59.8K | ﹤0.01% | 2415 |
|
|
2019
Q3 | $1.58M | Sell |
51,521
-38,579
| -43% | -$959K | ﹤0.01% | 2401 |
|
|
2019
Q2 | $1.8M | Buy |
90,100
+27,950
| +45% | +$819K | ﹤0.01% | 2383 |
|
|
2019
Q1 | $2.68M | Sell |
62,150
-7,841
| -11% | -$284K | ﹤0.01% | 2164 |
|
|
2018
Q4 | $2.23M | Sell |
69,991
-17,979
| -20% | -$709K | ﹤0.01% | 2176 |
|
|
2018
Q3 | $4.62M | Buy |
87,970
+13,223
| +18% | +$742K | ﹤0.01% | 1855 |
|
|
2018
Q2 | $4M | Sell |
74,747
-983
| -1% | -$50.4K | ﹤0.01% | 1926 |
|
|
2018
Q1 | $3.79M | Buy |
75,730
+14,517
| +24% | +$651K | ﹤0.01% | 1998 |
|
|
2017
Q4 | $2.02M | Buy |
61,213
+708
| +1% | +$23.9K | ﹤0.01% | 2343 |
|
|
2017
Q3 | $2.27M | Buy |
60,505
+1,505
| +3% | +$44.5K | ﹤0.01% | 2236 |
|
|
2017
Q2 | $1.5M | Buy |
59,000
+2,950
| +5% | +$73K | ﹤0.01% | 2408 |
|
|
2017
Q1 | $1.46M | Buy |
56,050
+3,130
| +6% | +$90.2K | ﹤0.01% | 2395 |
|
|
2016
Q4 | $1.61M | Buy |
52,920
+2,050
| +4% | +$52.1K | ﹤0.01% | 2326 |
|
|
2016
Q3 | $1.38M | Sell |
50,870
-2,550
| -5% | -$70.8K | ﹤0.01% | 2409 |
|
|
2016
Q2 | $1.53M | Sell |
53,420
-2,330
| -4% | -$74.1K | ﹤0.01% | 2355 |
|
|
2016
Q1 | $1.68M | Sell |
55,750
-930
| -2% | -$26.4K | ﹤0.01% | 2320 |
|
|
2015
Q4 | $1.97M | Sell |
56,680
-3,430
| -6% | -$117K | ﹤0.01% | 2120 |
|
|
2015
Q3 | $2.27M | Sell |
60,110
-2,390
| -4% | -$111K | 0.01% | 1916 |
|
|
2015
Q2 | $3.56M | Buy |
62,500
+1,580
| +3% | +$89.9K | 0.01% | 1665 |
|
|
2015
Q1 | $3.55M | Buy |
60,920
+948
| +2% | +$50.9K | 0.01% | 1581 |
|
|
2014
Q4 | $3.4M | Sell |
59,972
-3,238
| -5% | -$154K | 0.01% | 1501 |
|
|
2014
Q3 | $2.58M | Sell |
63,210
-10,830
| -15% | -$498K | 0.01% | 1535 |
|
|
2014
Q2 | $3.37M | Buy |
74,040
+15,583
| +27% | +$655K | 0.01% | 1456 |
|
|
2014
Q1 | $2.77M | Buy |
58,457
+9,537
| +19% | +$434K | 0.01% | 1589 |
|
|
2013
Q4 | $2.3M | Sell |
48,920
-6,501
| -12% | -$284K | 0.01% | 1683 |
|
|
2013
Q3 | $2.21M | Buy |
55,421
+6,750
| +14% | +$265K | 0.01% | 1613 |
|
|
2013
Q2 | $1.73M | Buy |
+48,671
| New | +$1.86M | ﹤0.01% | 1658 |
|
Other funds holding HBIO
WCM
VCM
CCM
MIM
NCNMGF
Jim Simons's HBIO Position: Q1 2026 in Review
Jim Simons reduced its Harvard Bioscience (HBIO) stake by 0.68% in Q1 2026, selling an estimated $3.9K and leaving 101,427 shares worth $494K. The position accounts for ﹤0.01% of the portfolio, ranked #2605.
Jim Simons first reported a position in HBIO in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.3M in Q2 2021. 37 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.
- Jim Simons held 101,427 shares of Harvard Bioscience worth $494K as of Q1 2026.
- Jim Simons sold 697 Harvard Bioscience shares in Q1 2026, an estimated $3.9K.
- Harvard Bioscience made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2605 holding.
- Jim Simons first reported a position in Harvard Bioscience in Q2 2013 and has held it in 52 quarters since.
- Jim Simons's Harvard Bioscience position peaked at $10.3M in Q2 2021.
- 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.